Pular para o conteúdo principal

ADCY5-related dyskinesia

ADCY5-related dyskinesia is a movement disorder; the term "dyskinesia" refers to abnormal involuntary movements. The abnormal movements that occur in ADCY5-related dyskinesia typically appear as sudden (paroxysmal) jerks, twitches, tremors, muscle tensing (dystonia), or writhing (choreiform) movements, and can affect the limbs, neck, and face.

Descrição

ADCY5-related dyskinesia is a movement disorder; the term "dyskinesia" refers to abnormal involuntary movements. The abnormal movements that occur in ADCY5-related dyskinesia typically appear as sudden (paroxysmal) jerks, twitches, tremors, muscle tensing (dystonia), or writhing (choreiform) movements, and can affect the limbs, neck, and face.

The abnormal movements associated with ADCY5-related dyskinesia usually begin between infancy and late adolescence. They can occur continually during waking hours, and frequently also disturb sleep. The involuntary movements often occur when changing position, such as from sitting to standing, or when deliberately making other movements.

Severely affected infants may experience weak muscle tone (hypotonia) and delay in development of motor skills such as crawling and walking; later, these individuals may have difficulties with activities of daily living and may eventually require a wheelchair. In more mildly affected individuals, the condition has little impact on walking and other motor skills, although the abnormal movements can lead to clumsiness or difficulty with social acceptance in school or other situations.

In some people with ADCY5-related dyskinesia, the disorder is generally stable throughout their lifetime. In others, it slowly gets worse (progresses) in both frequency and severity before stabilizing or even improving in middle age. Anxiety, fatigue, and other stress can temporarily increase the severity of the signs and symptoms of ADCY5-related dyskinesia, while some affected individuals may experience remission periods of days or weeks without abnormal movements. Life expectancy is not usually affected by ADCY5-related dyskinesia, and most people with this condition have normal intelligence.

Padrões de herança

The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.

Other names

Familial dyskinesia with facial myokymia

FDFM

Related patient information and medicines

Medicamentos antipsicóticos

Patient information leaflet

Medicamentos antipsicóticos

Movimento disorders develop in some cases. These include: Parkinsonismo - this can cause symptoms similar to those that occur in people with medicamentos para Parkinson doença medicamentos para Parkinson disease - for example, tremor and tensão muscular stiffness. Discinesia tardia (TD) - this is a movement disorder that can occur in some people who have taken antipsychotics for several.

Blefaroespasmo

Patient information leaflet

Blefaroespasmo

Discinesia tardia (see below). Tourette's syndrom... Deep brain stimulation Deep brain stimulation has been used (very rarely) for blepharospasm which is a part of Meige syndrome. Is tardive dyskinesia related para blepharospasm. Discinesia tardia is a movement disorder that results from taking certain medication, particularly a class of medicines.

Doença de Parkinson

Patient information leaflet

Doença de Parkinson

A main symptoms of Parkinson's disease are usually stiffness, shaking (tremor), and slowness of movement. Doença de Parkinson é a progressive neurological degeneration of certain cells (called dopaminergic cells) within a specific part of the brain (substantia nigra). Three common PD symptoms that gradually develop are: Slowness of movement.

Mutismo seletivo

Patient information leaflet

Mutismo seletivo

Mutismo seletivo involves being unable to speak or communicate in specific social situations, tais como at school, work, or in the community.

Posso tomar Lansoprazol e Quetiapina juntos?

Patient information leaflet

Posso tomar Lansoprazol e Quetiapina juntos?

Tomar lansoprazole and quetiapine together may increase the risk of a rare but serious heart rhythm problem. It can also potentially change how much quetiapine is absorbed into your body. Why this happens Lansoprazole Lansoprazole to reduce stomach acid reduces stomach acid, which can change how quetiapine Quetiapine dissolves and is absorbed. By.

Posso tomar Atorvastatina e Maitake juntos?

Patient information leaflet

Posso tomar Atorvastatina e Maitake juntos?

Tomar maitake mushrooms alongside atorvastatin pode increase the risk of muscle-related side effects or doença hepática irritation. It may also cause your blood sugar or cholesterol levels to drop lower than expected. Speak to your doctor before taking atorvastatin Atorvastatin tablets and maitake together as combining them may increase the risk of.

Leitura adicional e referências

Histórico do artigo

As informações nesta página são escritas e revisadas por clínicos qualificados.
  • 18 Aug 2023 | Última versão
  • 1 Jul 2015 | Publicado originalmente

Participe da conversa

Compartilhe seus pensamentos ou experiências com outros em nosso comunidades de pacientes.

Aviso: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmácia online, tratamentos e serviços de saúde

Acesso simples a tratamentos confiáveis e serviços de saúde online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscreva-se no boletim informativo do Patient

Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.

Por favor, insira um endereço de e-mail válido

Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.